ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: TH-OR20

Biofunctionalized Vascular Access Graft Enhanced Patency and Endothelialization in a Pig Arteriovenous (AV) Model

Session Information

Category: Dialysis

  • 703 Dialysis: Vascular Access

Authors

  • Selvakumar, Prakash Parthiban, University of Colorado Boulder, Boulder, Colorado, United States
  • Uriyanghai, Unimunkh, University of North Carolina System, Chapel, North Carolina, United States
  • Johnson, Richard Douglas, University of Colorado Boulder, Boulder, Colorado, United States
  • Wai, Christine, University of North Carolina System, Chapel, North Carolina, United States
  • Roy-Chaudhury, Prabir, University of North Carolina System, Chapel, North Carolina, United States
  • Tan, Wei, University of Colorado Boulder, Boulder, Colorado, United States
Background

Dialysis vascular access is currently both the “Lifeline” and the “Achilles heel” of dialysis vascular access. Dialysis access grafts suffer from clinical complications such as kinking, thrombosis, restenosis, and lack of rapid endothelialization. An anti-kinkable vascular access graft which promotes rapid endothelialization, thus restricting thrombosis and restenosis is a clinical necessity. Previously, we have successfully developed an acellular vascular graft which showed promising results in small animals. Here, we have reinforced the same graft to provide anti-kinking properties, and examined its effectiveness in a large animal model of AV stenosis.

Methods

6 mm graft comprising poly-ε-caprolactone (PCL) and polyethylene glycol norbornene (PEG-NB) was coaxially electrospun with PCL as the core and PEG-NB as the sheath and conjugated with various biomolecules. Biodegradable polydioxane sutures were spirally wound for anti-kinkability. These grafts were implanted in a loop configuration between the femoral artery and vein of pigs. Computer tomography (CT; weeks 1 and 4) and Doppler ultrasound examination (a week for 4 weeks) was performed. The grafts were removed after 28d for histological examination.

Results

We observed no kinking of the grafts during the test period. The CT scan showed a patent lumen with continuous blood flow. Ultrasounds documented patency and an average volume flow of 756.3 ml/min (Fig. 1a-c). Histology revealed active cellular integration, ECM synthesis and the formation of a luminal endothelial layer (Fig. 1d).

Conclusion

Our electrospun grafts with precision engineered biomolecules, promoted rapid endothelialization and cellular integration with good flow, in an arteriovenous configuration. This approach will reduce the huge morbidity, mortality and economic cost currently associated with dialysis vascular access dysfunction.